GlassScriptPhysician profile
John Frankel
NPI 1679991665
$5,361.70
in general payments reported to CMS, 2019-2025
13 companies · $1,958 in 2025
The $1,958 reported for 2025 was more than what 82% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,000 · 2020: $39.88 · 2021: $130 · 2022: $180 · 2023: $849 · 2024: $205 · 2025: $1,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,760 · Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,760.00 |
| Food and Beverage | $1,251.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,159.17 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $1,933.48 | 2021-2025 | Enseal X1, Echelon; Endopath |
| Axonics, INC. | $432.28 | 2023-2024 | Axonics |
| Stryker Corporation | $215.22 | 2023 | Spy-Phi System |
| Medtronic, INC. | $196.67 | 2022-2023 | Ligasure |
| Boston Scientific Corporation | $145.00 | 2025 | Axonics |
| Pacira Pharmaceuticals Incorporated | $110.00 | 2019 | |
| Baxter Healthcare | $42.63 | 2023 | Tisseel |
| Abbvie INC. | $42.02 | 2023-2024 | |
| Olympus America INC. | $33.18 | 2024-2025 | Itind System |
| Alexion Pharmaceuticals, INC. | $18.95 | 2025 | Ultomiris |
| Antares Pharma, INC. | $17.88 | 2025 | Xyosted |
| Conmed Corporation | $15.22 | 2023 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Frankel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.